-- Novo Nordisk A/S’s reign as Europe’s most valuable company “leaves no room to disappoint” with its first-quarter report, said Bloomberg Intelligence’s Michael Shah.Blade to Offer Luxury Bus Service to Hamptons at Fare Up to $275
British oil major Shell Plc also reports this week, when investors will probably look past a weaker first quarter with the energy sector poised to regain momentum following a price rebound, BI said. Italian bank Intesa Sanpaolo SpA completes the lineup.Tuesday: Stellantis’ sales update will probably show it’s coping with falling demand in Europe’s electric-vehicle market, for now. Revenue for the Enlarged Europe segment likely grew 1.
Thursday: Novo Nordisk probably sold 10.4 billion Danish kroner’s worth of its blockbuster weight-loss drug Wegovy in the first quarter, more than twice the year-earlier figure, consensus shows. A steady ramp-up in starting dose scripts points to even bigger sales in the second half, Barclays said. Don’t be surprised if the company adjusts its full-year outlook as consensus is already close to the top of the forecast range, Citi said.
Here’s How Much You’d Have Now If You Invested $1,000 in Warren Buffett’s Berkshire Hathaway 10 Years Ago Billionaire hedge fund boss David Einhorn shared his thoughts about why gold has soared this year in his most recent letter to investors.Tony Robbins: 6 ‘Golden Rules’ of Investing That Can Make You Rich
المملكة العربية السعودية أحدث الأخبار, المملكة العربية السعودية عناوين
Similar News:يمكنك أيضًا قراءة قصص إخبارية مشابهة لهذه التي قمنا بجمعها من مصادر إخبارية أخرى.
Luxury segment, Stellantis are outliers in an otherwise up sales marketpFebruary sales were up 24.4 per cent, but March sales were up only 9.2 per cent as a split developed: Many mainstream brands are posting large gains, while most luxury brands are down/p
مصدر: AutoNewsCanada - 🏆 77. / 51 اقرأ أكثر »